![Mauro Ferrari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mauro Ferrari
Director/Board Member at
ARROWHEAD PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 2026-09-29
Profile
Mauro Ferrari was the founder of Nanomedical Systems, Inc. (founded in 2007) and served as Director.
Dr. Ferrari is also the founder of Leonardo BioSystems, Inc...
Dr. Ferrari is Chief Executive Officer at Dxt Pharmaceutics.
Dr. Ferrari is Chairman, President & Chief Executive Officer at BrYet US, Inc. Dr. Ferrari is Independent Director at Arrowhead Pharmaceuticals, Inc. since 2010.
Dr. Ferrari is Director at BioHouston, Inc. Dr. Ferrari is Professor at the University of Washington.
Dr. Ferrari is President at The Alliance for NanoHealth.
Dr. Ferrari was President & Chief Executive Officer at The Methodist Hospital Research Institute from 2010 to 2019.
Dr. Ferrari was Executive Vice President at The Methodist Hospital from 2010 to 2019.
Dr. Ferrari was Professor at The Ohio State University.
Dr. Ferrari was Professor at the University of California, Berkeley.
Dr. Ferrari was Professor at The University of Texas M.D.
Anderson Cancer Center.
Dr. Ferrari was Senior Associate Dean at Weill Cornell Medical College from 2010 to 2019.
Dr. Ferrari was President at European Research Council.
Dr. Ferrari was Professor at The University of Texas Health Science Center at Houston.
Dr. Ferrari earned a doctorate from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-14 | 69,053 ( 0.05% ) | 5 M $ | 2026-09-29 |
Mauro Ferrari active positions
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2010-08-18 |
Dxt Pharmaceutics | Chief Executive Officer | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
BioHouston, Inc.
 BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Director/Board Member | - |
The Alliance for NanoHealth
 The Alliance for NanoHealth The Alliance for NanoHealth (ANH) is a collaborative research consortium centered around the Texas Medical Center, uniting eight academic and clinical institutions to integrate nanotechnology with medicine, biology, materials science, computer technology, and public policy. The private company is based in Houston, TX. The organization develops nanotechnology-based clinical solutions to improve diagnosis, treatment, and prevention of major diseases such as cancer, heart disease, diabetes, stroke, and infections. ANH fosters multidisciplinary collaboration through shared infrastructure and advanced research facilities, supports educational and training programs, and recognizes investigators contributing to multi-institutional projects. The consortium partners with the FDA-ANH Nanotechnology Initiative to address scientific and translational challenges in developing nanoengineered medical products. ANH disseminates research findings and hosts expert presentations to advance nanomedicine, serving as a hub for accelerating nanotechnology research and innovation in healthcare. | President | - |
BrYet US, Inc. | Chief Executive Officer | - |
Former positions of Mauro Ferrari
| Companies | Position | End |
|---|---|---|
The Methodist Hospital
 The Methodist Hospital Hospital/Nursing ManagementHealth Services Owns and operates general medical hospitals | Corporate Officer/Principal | 2018-12-31 |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2018-12-31 |
The Methodist Hospital Research Institute | Chief Executive Officer | 2018-12-31 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Education of Mauro Ferrari
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Nanomedical Systems, Inc.
 Nanomedical Systems, Inc. Medical SpecialtiesHealth Technology Develops silicon-based medical nanotechnology devices | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Methodist Hospital
The Methodist Hospital Hospital/Nursing ManagementHealth Services Owns and operates general medical hospitals | Health Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Commercial Services |
The Methodist Hospital Research Institute | |
Leonardo BioSystems, Inc.
 Leonardo BioSystems, Inc. Packaged SoftwareTechnology Services Prepackaged Software | Technology Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Research Council
 European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Miscellaneous |
The Alliance for NanoHealth
The Alliance for NanoHealth The Alliance for NanoHealth (ANH) is a collaborative research consortium centered around the Texas Medical Center, uniting eight academic and clinical institutions to integrate nanotechnology with medicine, biology, materials science, computer technology, and public policy. The private company is based in Houston, TX. The organization develops nanotechnology-based clinical solutions to improve diagnosis, treatment, and prevention of major diseases such as cancer, heart disease, diabetes, stroke, and infections. ANH fosters multidisciplinary collaboration through shared infrastructure and advanced research facilities, supports educational and training programs, and recognizes investigators contributing to multi-institutional projects. The consortium partners with the FDA-ANH Nanotechnology Initiative to address scientific and translational challenges in developing nanoengineered medical products. ANH disseminates research findings and hosts expert presentations to advance nanomedicine, serving as a hub for accelerating nanotechnology research and innovation in healthcare. | |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BrYet US, Inc. | |
Dxt Pharmaceutics |
- Stock Market
- Insiders
- Mauro Ferrari
